Plasma Fractionation Market Worth $ 35.02 Billion, Globally, by 2027 at 5.75% CAGR: Verified Market Research

Plasma Fractionation Market Worth $ 35.02 Billion, Globally, by 2027 at 5.75% CAGR: Verified Market Research

PR Newswire

JERSEY CITY, N.J., Oct. 7, 2020

Market is growing at a rapid pace owing to the increasing use of Immunoglobulins in various therapeutic areas, rising geriatric population, and the growing prevalence of respiratory diseases

JERSEY CITY, N.J., Oct. 7, 2020 /PRNewswire/ -- Verified Market Research recently published a report, "Plasma Fractionation Market by Product (Coagulation Factors, Immunoglobulins, Protease Inhibitors, Anticoagulants, Albumins), by Application (Hematology, Hemato-Oncology, Rheumatology, Immunology, Neurology), Geography". According to Verified Market Research, the Global Plasma Fractionation Market was valued at USD 22.41 Billion in 2019 and is projected to reach USD 35.02 Billion by 2027, growing at a CAGR of 5.75 % from 2020 to 2027.

Plasma Fractionation Market Analysis & Forecast, 2020-2027

This report provides detailed analysis of the growth trends among each of the segments as well as accurate forecasts in terms of the value and volume.

Download PDF Brochure:

Browse in-depth TOC on "Plasma Fractionation Market"

202 - Pages
126 – Tables
37 – Figures

Global Plasma Fractionation Market Overview

The growing incidences of blood and immune disorders owing to the increasing geriatric population, along with increasing off-label-usage of critical plasma products such as albumins, and Immunoglobulins is the major factor driving the growth of the global plasma fractionation market. The rise in the use of immunoglobulins and alpha-1-antitrypsin in areas of medicine across the globe also fuels the growth of the plasma fractionation market. In the last few years, the diagnosis of various immunological diseases has increased due to technological advancement, which in turn is also expected to drive the market growth. Furthermore, numerous advancements in the product by major manufacturers is also one of the major factor contributing to the growth of the plasma fractionation market across the globe.

Enhanced diagnostic facilities, and ease of access to healthcare coupled with increasing incidences and prevalence of chronic diseases across the globe, are some factors responsible for the upcoming demand for plasma-derived products and is anticipated to drive the plasma fractionation market during the forecast period of 2020-2027. The COVID-19 outbreak has urged scientists to experiment with plasma therapy on affected people as there is no vaccine or specific treatment available against these diseases. Hence the positive result shown by plasma therapy in disease management and recovery will create opportunities for the market over the forecast period.

Major players in this market are – CSL (Australia), Grifols (Spain), Shire (Ireland), Octapharma (Switzerland), Kedrion (Italy), LFB (France), Biotest (Germany), Sanquin (Netherlands), China Biologic Products (UK), and Bio Products Laboratory (UK)

Verified Market Research has segmented the Global Plasma Fractionation Market on the basis of Product, Application, and Geography.

Plasma Fractionation Market by Geography

Browse Related Reports:

Hearing Aids Market by Product (Hearing Aid Devices, Hearing Implants), by Type of Hearing Loss (Sensorineural Hearing Loss, Conductive Hearing Loss), by Patient Type (Adults, Pediatrics), Geography and Forecast, 2020-2027

Ophthalmic Equipment Market by Product (Diagnostic and Monitoring Devices, Refractive Surgical Devices, Glaucoma Surgical Devices, Cataract Surgical Devices, Vision Care Products), by End-User (Consumers, Hospitals), Geography, Forecast, 2019-2026

DTC Genetic Testing Market by Test Type (Carrier Testing, Predictive Testing, Nutrigenomic Testing, Ancestry & Relationship Testing), by Technology (Targeted analysis, Single nucleotide polymorphism (SNP) chips, Whole genome sequencing (WGS)), Geography, Forecast, 2019-2026

Radiation Dose Management Market by Products & Services (Consulting Services, Education and training services, Support and maintenance, Implementation and Integration), by End-User (Hospitals, Ambulatory Care Settings, Research Institutes and Medical Centers), by Modality (Computed Tomography, Fluoroscopy and Interventional Imaging, Radiography and Mammography, Nuclear Medicine), Geography, Forecast, 2020-2027

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (203)-411-9686
APAC: +91 (902)-863-5784
US Toll Free: +1 (800)-782-1768
Follow Us: LinkedIn | Twitter 


Voltar noticias em Inglês